Abstract
CD4+CD25+ regulatory T cells (Tregs) play an important role in maintaining host immune tolerance via regulation of the phenotype and function of the innate and adaptive immune cells. Whether allogeneic CD4+CD25+ Tregs can regulate recipient mouse macrophages is unknown. The effect of allogeneic donor CD4+CD25+ Tregs on recipient mouse resident F4/80+macrophages was investigated using a mouse model in which allogeneic donor CD4+CD25+ Tregs were adoptively transferred into the peritoneal cavity of host NOD-scid mice. The phenotype and function of the recipient macrophages were then assayed. The peritoneal F4/80+ macrophages in the recipient mice that received the allogeneic CD4+CD25+ Tregs expressed significantly higher levels of CD23 and programmed cell death-ligand 1(PD-L1) and lower levels of CD80, CD86, CD40 and MHC II molecules compared to the mice that received either allogeneic CD4+CD25− T cells (Teffs) or no cells. The resident F4/80+ macrophages of the recipient mice injected with the allogeneic donor CD4+CD25+ Tregs displayed significantly increased phagocytosis of chicken red blood cells (cRBCs) and arginase activity together with increased IL-10 production, whereas these macrophages also showed decreased immunogenicity and nitric oxide (NO) production. Blocking arginase partially but significantly reversed the effects of CD4+CD25+ Tregs with regard to the induction of the M2 macrophages in vivo. Therefore, the allogeneic donor CD4+CD25+ Tregs can induce the M2 macrophages in recipient mice at least in part via an arginase pathway. We have provided in vivo evidence to support the unknown pathways by which allogeneic donor CD4+CD25+ Tregs regulate innate immunity in recipient mice by promoting the differentiation of M2 macrophages.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Biswas SK, Mantovani A . Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889–896.
Rafei M, Hsieh J, Zehntner S, Li M, Forner K, Birman E et al. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med 2009; 15: 1038–1045.
Gordon S . Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23–35.
Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T et al. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 2011; 34: 385–395.
Kuroda E, Ho V, Ruschmann J, Antignano F, Hamilton M, Rauh MJ et al. SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils. J Immunol 2009; 183: 3652–3660.
Gordon S, Martinez FO . Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593–604.
Varin A, Gordon S . Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009; 214: 630–641.
Schreiber T, Ehlers S, Heitmann L, Rausch A, Mages J, Murray PJ et al. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol 2009; 183: 1301–1312.
Pollard JW . Trophic macrophages in development and disease. Nat Rev Immunol 2009; 9: 259–270.
Hashimoto M, Hirota K, Yoshitomi H, Maeda S, Teradaira S, Akizuki S et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med 2010; 207: 1135–1143.
Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007; 447: 1116–1120.
Mosser DM . The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209–212.
Taams LS, van Amelsfort JM, Tiemessen MM, Jacobs KM, de Jong EC, Akbar AN et al. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol 2005; 66: 222–230.
Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS . CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 2007; 104: 19446–19451.
Liu G, Ma H, Qiu L, Li L, Cao Y, Ma J et al. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol Cell Biol 2011; 89: 130–142.
Johrens K, Franke A, Dietel M, Anagnostopoulos I . Non-neoplastic TdT-positive cells in bone marrow trephines with acute myeloid leukaemia before and after treatment express myeloid molecules. Pathobiology 2011; 78: 35–40.
Zhang J, Adrian FJ, Jahnke W, Cowan-Jacob SW, Li AG, Iacob RE et al. Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature 2010; 463: 501–506.
Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C et al. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol 2010; 185: 3866–3872.
Peggs KS, Mackinnon S . Exploiting graft-versus-tumour responses using donor leukocyte infusions. Best Pract Res Clin Haematol 2001; 14: 723–739.
Korngold R . Pathophysiology of graft-versus-host disease directed to minor histocompatibility antigens. Bone Marrow Transplant 1991; 7( Suppl 1): 38–41.
Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117: 3921–3928.
Rezvani AR, Storb RF . Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 2008; 30: 172–179.
Liu G, Burns S, Huang G, Boyd K, Proia RL, Flavell RA et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol 2009; 10: 769–777.
Sun Z, Zhao L, Wang H, Sun L, Yi H, Zhao Y . Presence of functional mouse regulatory CD4+CD25+ T cells in xenogeneic neonatal porcine thymus-grafted athymic mice. Am J Transplant 2006; 6: 2841–2850.
Joerink M, Ribeiro CM, Stet RJ, Hermsen T, Savelkoul HF, Wiegertjes GF . Head kidney-derived macrophages of common carp (Cyprinus carpio L.) show plasticity and functional polarization upon differential stimulation. J Immunol 2006; 177: 61–69.
Liu G, Ma H, Jiang L, Peng J, Zhao Y . The immunity of splenic and peritoneal F4/80+ resident macrophages in mouse mixed allogeneic chimeras. J Mol Med (Berl) 2007; 85: 1125–1135.
Wang H, Zhao L, Sun Z, Sun L, Zhang B, Zhao Y . A potential side effect of cyclosporin A: inhibition of CD4+CD25+ regulatory T cells in mice. Transplantation 2006; 82: 1484–1492.
Liu G, Xia XP, Gong SL, Zhao Y . The macrophage heterogeneity: difference between mouse peritoneal exudate and splenic F4/80+ macrophages. J Cell Physiol 2006; 209: 341–352.
Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S . Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007; 179: 977–983.
Anthony RM, Urban JF Jr, Alem F, Hamed HA, Rozo CT, Boucher JL et al. Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 2006; 12: 955–960.
Weng M, Huntley D, Huang IF, Foye-Jackson O, Wang L, Sarkissian A et al. Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis. J Immunol 2007; 179: 4721–4731.
Hayashi A, Ohnishi H, Okazawa H, Nakazawa S, Ikeda H, Motegi S et al. Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages. J Biol Chem 2004; 279: 29450–29460.
Rauh MJ, Ho V, Pereira C, Sham A, Sly LM, Lam V et al. SHIP represses the generation of alternatively activated macrophages. Immunity 2005; 23: 361–374.
Liu GW, Ma HX, Wu Y, Zhao Y . The nonopsonic allogeneic cell phagocytosis of macrophages detected by flow cytometry and two photon fluorescence microscope. Transpl Immunol 2006; 16: 220–226.
Van Ginderachter JA, Meerschaut S, Liu Y, Brys L, de Groeve K, Hassanzadeh Ghassabeh G et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 2006; 108: 525–535.
Liu G, Yang K, Burns S, Shrestha S, Chi H . The S1P1–mTOR axis directs the reciprocal differentiation of TH1 and Treg cells. Nat Immunol 2010; 11: 1047–1056.
Tzachanis D, Berezovskaya A, Nadler LM, Boussiotis VA . Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood 2002; 99: 1465–1473.
Martinez FO, Gordon S, Locati M, Mantovani A . Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303–7311.
Hoves S, Krause SW, Schutz C, Halbritter D, Scholmerich J, Herfarth H et al. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol 2006; 177: 2691–2698.
Raes G, Beschin A, Ghassabeh GH, de Baetselier P . Alternatively activated macrophages in protozoan infections. Curr Opin Immunol 2007; 19: 454–459.
Loke P, Gallagher I, Nair MG, Zang X, Brombacher F, Mohrs M et al. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 2007; 179: 3926–3936.
Ogawa K, Funaba M, Chen Y, Tsujimoto M . Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol 2006; 177: 6787–6794.
Mantovani A, Locati M . Orchestration of macrophage polarization. Blood 2009; 114: 3135–3136.
Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci USA 2009; 106: 14978–14983.
Acknowledgements
The authors wish to thank Drs Shuping Zhou and Zeqing Niu for their kind review of the manuscript, Ms Jing Wang, Mr Yabing Liu and Ms Xiaoqiu Liu for their expert technical assistance, Ms Qinghuan Li and Jianxia Peng for their excellent laboratory management and Mr Baisheng Ren for his outstanding animal husbandry. This work was supported by grants from the National Natural Science Foundation (C81072396, U0832003, YZ; C31171407 and 81273201, GL), the Ministry of Science and Technology of China (2010CB945301, YZ) and the Chinese Academy of Sciences for Distinguished Young Scientists (KSCX2-EW-Q-7, GL)..
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors have declared that no conflict of interests exists.
Additional information
Supplementary Information accompanies the paper on Cellar & Molecular Immunology's website (http://www.nature.com/cmi)
Supplementary information
Rights and permissions
About this article
Cite this article
Hu, X., Liu, G., Hou, Y. et al. Induction of M2-like macrophages in recipient NOD-scid mice by allogeneic donor CD4+CD25+ regulatory T cells. Cell Mol Immunol 9, 464–472 (2012). https://doi.org/10.1038/cmi.2012.47
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2012.47
Keywords
This article is cited by
-
MicroRNA in extracellular vesicles regulates inflammation through macrophages under hypoxia
Cell Death Discovery (2021)
-
Gpr174-deficient regulatory T cells decrease cytokine storm in septic mice
Cell Death & Disease (2019)
-
HIF1α-dependent glycolysis promotes macrophage functional activities in protecting against bacterial and fungal infection
Scientific Reports (2018)
-
TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway
Cellular & Molecular Immunology (2016)
-
TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide
Journal of Molecular Medicine (2016)